SavedAdd your journal

Journals / Journal of Emergency Medicine Case Reports / 2023 / Cilt: 14 - Sayı: 1

Platypnea-Orthodeoxia Syndrome Associated with COVID-19 Pneumonia and Prolonged Treatment Due to Tamsulosin Use: A Case Report

Muhammet KIZMAZ
Ayşe TURUNÇ ÖZDEMİR
Zeynep ALKAN
Pages
7–9
Publication Date
2023-04-07
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The case we present suggests that alpha-blockers may also be related to pathophysiology.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Platypnea-orthodeoxia syndrome (POS) is an extremely rare condition.
📊
Key Findings & Data:A 67-year-old male patient was hospitalized due to COVID-19.
💡
Conclusion & Impact:The case we present suggests that alpha-blockers may also be related to pathophysiology.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:COVID-19 · Platypnoea-orthodeoxia syndrome · SARS-CoV-2

Abstract

Platypnea-orthodeoxia syndrome (POS) is an extremely rare condition. There are no other cases in the literature where tamsulosin has been reported to prolong POS treatment. A 67-year-old male patient was hospitalized due to COVID-19. He was followed up in the ward after being in the intensive care unit for ten days. There was a significant decrease in saturation (SaO2) when sitting and standing compared to lying. He was diagnosed with POS. However, there was no significant improvement in POS with exercises. After stopping the tamsulosin he was using, there was a dramatic improvement. He was discharged on the 72nd day of his hospitalization. Due to COVID-19, POS is more likely to appear than before. It is a condition that clinicians should recognize. The pathophysiology of POS has not been fully elucidated. The case we present suggests that alpha-blockers may also be related to pathophysiology.

🔖

Cite This Article

KIZMAZ, M., ÖZDEMİR, A. T., ALKAN, Z. (2023). Platypnea-Orthodeoxia Syndrome Associated with COVID-19 Pneumonia and Prolonged Treatment Due to Tamsulosin Use: A Case Report. Journal of Emergency Medicine Case Reports, Cilt: 14 - Sayı: 1, 7–9. https://ajindex.com/articles/886735

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Agrawal A, Palkar A, Talwar A. The multiple dimensions of Platypnea-Orthodeoxia syndrome: A review. Respir Med. 2017; 129:31–38. 2-Burchell HBHHJ, Wood EH. Reflex orthostatic dyspnea associated with pulmonary hypotension. Am. J. Physiol. 1949; 159:563–564. 3-Altman M, Robin ED. Platypnea (diffuse zone I phenomenon?) N. Engl. J. Med. 1969; 281:1347–1348. 4-Robin ED, Laman D, Horn BR, Theodore J. Platypnea related to orthodeoxia caused by true vascular lung shunts. N. Engl. J. Med. 1976; 294:941–943. 5-Tan GP, Ho S, Fan BE, et al. Reversible platypnea-orthodeoxia in COVID-19 acute respiratory distress syndrome survivors. Respir Physiol Neurobiol. 2020 Nov;282:103515. doi: 10.1016/j.resp.2020.103515. 6-Longo C, Ruffini L, Zanoni N, et al. Platypnea-orthodeoxia after fibrotic evolution of SARS-CoV-2 interstitial pneumonia. A case report. Acta Biomed. 2020 Aug;91(3):e2020052. doi:10.23750/abm.v91i3.10386. 7-Singh K, Kadnur H, Ray A, et al. Platypnea-orthodeoxia in a patient with severe COVID-19 pneumonia. Monaldi Arch Chest Dis. 2020 Dec;90(4). doi: 10.4081/monaldi.2020.1609. 8-Tham SL, Ong PL, Lee AJY, Tay MRJ. Rehabilitation of Patients with Platypnea-Orthodeoxia Syndrome in COVID-19 Pneumonia: Two Case Reports. J Rehabil Med Clin Commun. 2020 Nov;3:1000044. doi:10.2340/20030711-1000044. 9- Aayilliath K A, Singh K, Ray A, Wig N. Platypnoea-orthodeoxia syndrome in COVID-19. BMJ Case Rep. 2021 May;14(5):e243016. doi:10.1136/bcr-2021-243016. 10- Agrawal A, Palkar A, Talwar A. The multiple dimensions of platypnea-orthodeoxia syndrome: a review. Respir Med. 2017;129:31–8.